Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model.
Odenstedt
Jacob
J
Cardiovascular Institute, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden. Jacob.Odenstedet@vgregion.se
Månsson
Chrichan
C
Grip
Lars
L
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004195:Disease Models, Animal; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D011725:Pyridines / Q000494:pharmacology*; D013552:Swine; D014693:Ventricular Fibrillation / Q000503:physiopathology
D002121:Calcium Channel Blockers; D011725:Pyridines; C118563:clevidipine